Data from the Hong Kong Stock Exchange shows that on July 24, The Capital Group Companies, Inc. increased its holdings in HENGRUI PHARMA (01276) by 752,200 shares.
The shares were acquired at an average price of HK$56.7648 each, resulting in a total transaction value of approximately HK$42.6985 million.
Following this purchase, the investment firm's total shareholding in Hengrui Pharma now stands at around 23.6978 million shares, representing a 9.18% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments